盆腔器官廓清术在复发宫颈癌治疗中的价值  

Role of pelvic exenteration in the treatment of recurrent cervical cancer

作　　者：刘继红[1] 黄鹤[1] 万挺[1] LIU Ji-hong;HUANGHe;WAN Ting(Department of Gynecologic Oncology,Sun Yat-sen University Cancer Center,Guangzhou 510060,China)

机构地区：[1]中山大学附属肿瘤医院妇科,广东广州510060

出　　处：《中国实用妇科与产科杂志》2018年第11期1223-1226,共4页Chinese Journal of Practical Gynecology and Obstetrics

摘　　要：盆腔器官廓清术(盆廓术)为中央型盆腔复发的宫颈癌患者提供了再次治愈的机会。姑息性盆廓术对部分周围型复发患者也可以起到减轻症状和改善生活质量的作用。满意的手术切缘是影响盆廓术疗效和患者预后的最重要因素。术前需要根据患者的临床表现、妇科检查、影像学检查进行重点评估,并综合患者既往治疗情况、一般机体状态、患者心理、术中探查情况等综合考虑,筛选合适病例,并选择合理的手术方式和入路,才能使复发宫颈癌患者从盆廓术中获益。Pelvic exenteration offers another chance of cure for cervical cancer patients with recurrent diseases in central pelvis.For those with recurrence of lateral pelvic wall,palliative pelvic exenteration can also play a role in relieving symptoms and improving the quality of life.Surgical margin is the most important factor for prognosis after this surgery. Therefore,it is critical to have evaluation before surgery,considering the possibility of clear margin according to clinical manifestation,pelvic examination and imaging characteristics,combined with the history of treatment,general physical and psychological status,as well as surgical exploration.Based on the careful selection of cases and operative approaches,the patients could benefit from the exenteration surgery.

关 键 词：宫颈肿瘤 局部晚期 盆腔脏器廓清术 子宫颈癌 复发 预后 

分 类 号：R737.3[医药卫生—肿瘤]